Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trials
Authors:
Guiomar Mendieta Badimon 1; Paul M. Ridker 2; Pernille Auerbach 3; Barry A. Borlaug 4; Maja Cikes 5; Anique Ducharme 6; Marat Fudim 7; Anders Hvelplund 3; Carolyn S.P. Lam 8; Marie Mide Michelsen 3; Adriaan A. Voors 9; Mark C Petrie 10